News About: Pharm. Industry
The ARB-type hypertension singular drug market has suffered from depression… Boryung is the only one grown
While the single drug market for domestic ARB-type hypertension treatments has been decreased, Boryung Pharm has kept its steady growth.
According to the Hana Daetoo Securities’s analysis result of the UBIST data, th...
Listed pharmaceutical companies were increased by 3.5% in stock prices
As stock prices of listed pharmaceutical companies have been increased by 3.5% in a month, they have received favorable comments of investors in the stock market.
According to the YakupDotCom’s analysis result of flu...
“I need to get you to hit the market”…two different contrasts in blockbuster-level pharmaceutical products last year
Last year, blockbuster-level pharmaceutical products had different score sheets in the outpatient market.
The recent data of outpatient prescription expenses by UBIST analyzed multinational pharmaceutical companies’ ...
Domestic and multinational companies focus on respective cardiovascular and anticancer treatments
Last year, domestic companies went for cardiovascular pharmaceutical products while multinational companies had focused on anticancer drugs.
According to the analysis result of the approval state of clinical trials i...
How much the pharmaceutical industry recognizeabout the Nagoya Protocol?
The Korea PharmaceuticalAssociation will conduct a survey to find recognition of the pharmaceutical industry towards the Nagoya Protocol reported 21 October 2014.
Since the key point of the Nagoya Protocol is for use...
‘Hanmi’ will also enter the fluid cold medicine market… what are the objectives?Fluid cold medicines, syrup type cold medicines showed for the first time in 2009, were a concept for the young.
Fluid cold medicines have recently entered in the market by Cho...
|
The labor-management dispute of Bayer get more interesting… the court debate has been triggered
The labor-management dispute of Bayer Korea has gone far away from the middle ground. It seems the dispute is going towards the court debate.
Bayer recentlyappliedan order of restricted access againstGi-hyung Kim, ch...
While sales of Insadol went ‘-12%’, Fulcare were increased by 400%
Last year, it is shown that sales of the Dongkook Pharmaceutical’s Insadolhave been hesitated, but the Menarini’sFulcare and the Ildong Pharmaceutical’s Aronamin Gold took a step forward.
However, sales of the Insado...
Bayer Korea appointed CEO Ingrid U. Drechsel as the new chief
Bayer Korea announced that it will appoint Ingrid U. Drechsel to the new CEO of Bayer Korea since 1 February 2015.
Shewill all the divisions of Bayer Korea, including Bayer Healthcare, Crop Science and Material Scien...
Will personnel typhoon occur in the pharmaceutical industry?... CEOs of 7 companies will be expired in their contracts
Along with the General Meeting on this March, the industry has paid attention in which professional managers of 7 listed pharmaceutical companies are expected to be expired in their contracts.
Although 10 professiona...
